PALO ALTO NETWORKS INC: JP MORGAN LOWERS TARGET PRICE FROM $225 TO $200
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 19 2026
0mins
Should l Buy PANW?
Source: moomoo
- Stock Price Adjustment: JPMorgan has reduced its target price for Palo Alto Networks from $225 to $200.
- Market Impact: This adjustment reflects changes in market conditions and expectations for the company's performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PANW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PANW
Wall Street analysts forecast PANW stock price to rise
34 Analyst Rating
28 Buy
5 Hold
1 Sell
Strong Buy
Current: 160.670
Low
157.00
Averages
232.49
High
265.00
Current: 160.670
Low
157.00
Averages
232.49
High
265.00
About PANW
Palo Alto Networks, Inc. is a global artificial intelligence (AI) cybersecurity company, with a comprehensive portfolio of cybersecurity solutions and platforms across network, cloud, security operations, AI and Identity. Its network security platform includes Secure Access Service Edge (SASE), Next-Generation Firewalls, Cloud Delivered Security Services (CDSS), Prisma AIRS, and Strata Cloud Manager (SCM). It delivers security operations capabilities that unifies standalone Security Information and Event Management (SIEM) tools, endpoint security, security automation, cloud detection and response (CDR), as well as attack surface management (ASM) capabilities on its Cortex platform. It delivers comprehensive security across the cloud application development lifecycle through Cortex Cloud. Its Unit 42 brings together expertise across threat research, incident response, and security consulting to deliver intelligence-driven, response-ready outcomes that help customers reduce cyber risk.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Palo Alto Networks CEO Buys $10 Million in Stock Amid Market Decline
- Insider Buying Signal: CEO Nikesh Arora's $10 million stock purchase following a 33% decline in Palo Alto Networks' share price indicates strong confidence in the company's future value, potentially boosting market sentiment towards the stock.
- Market Reaction Analysis: Despite a general decline in cybersecurity stocks due to concerns over generative AI, Palo Alto Networks is well-positioned to benefit from increased demand for comprehensive cybersecurity solutions as enterprises face growing threats, suggesting a strategic advantage.
- Platform Strategy Success: The company reported 1,550 platform customers as of Q2, a 35% year-over-year increase, reflecting the effectiveness of its platformization strategy in enhancing customer retention and achieving a net revenue retention rate of 119%, indicating growing customer reliance on its services.
- Software Business Growth: While overall revenue growth is hampered by legacy hardware, Palo Alto's high-margin software solutions grew by 33% last quarter, demonstrating strong market competitiveness in addressing AI-driven cyber threats and positioning the company for accelerated future growth.
See More
Palo Alto Networks CEO Purchases Shares, Stock Rises
- CEO Share Purchase: The CEO of Palo Alto Networks recently purchased shares, leading to a rise in stock price on the afternoon of March 29, 2026, indicating management's confidence in the company's future, which may attract more investor interest.
- Market Performance Comparison: Despite the CEO's stock purchase, the analyst team noted that Palo Alto Networks was not included in the current list of top investment stocks, reflecting differing market perceptions of its future growth potential, which could influence investor decisions.
- Return Rate Analysis: According to The Motley Fool, their Stock Advisor service boasts an average return rate of 914%, significantly outperforming the S&P 500's 184%, indicating that investors should carefully consider potential returns when selecting stocks.
- Industry Competitive Dynamics: Amid rapid advancements in AI technology, market interest in Palo Alto Networks is rising, particularly due to its critical technology needs linked to industry giants like Nvidia and Intel, potentially opening new growth opportunities for the company.
See More
Palo Alto Networks CEO Buys Shares, Stock Rises
- Stock Price Surge: Shares of Palo Alto Networks rose following news of the CEO's stock purchase, indicating increased market confidence in the company's future and heightened investor trust in management.
- CEO Purchase: The CEO bought shares at afternoon prices on March 29, 2026, demonstrating a strong belief in the company's prospects, which may attract more investor attention to the firm.
- Market Reaction: This purchase triggered a positive market response, with the stock price increase reflecting investor confidence in corporate governance and management, potentially fostering further investment and shareholder support.
- Strategic Implications: The CEO's purchase not only acknowledges the company's value but may also signal upcoming aggressive growth strategies, further enhancing the company's competitive position in the market.
See More
Lockheed Martin Hacked, Exposing Sensitive Data
- Cybersecurity Threats: Lockheed Martin was recently targeted in a hacking breach that may have exposed sensitive data, including information on the F-35 fighter jet, highlighting the critical importance of protecting classified weapons data amid increasingly sophisticated cybersecurity threats.
- Growing Market Demand: As artificial intelligence advances, cybersecurity is expected to remain a crucial budget item for companies worldwide, driving demand for cybersecurity firms, particularly those that excel in innovation.
- CrowdStrike's Market Leadership: CrowdStrike Holdings' Falcon platform leverages AI to analyze device activity and detect suspicious patterns, with its total addressable market projected to grow from $149 billion to $325 billion by 2030, indicating strong growth potential.
- Zscaler's Unique Positioning: Zscaler specializes in cloud-native zero-trust security, generating $3 billion in annual sales, and the zero-trust security market is expected to expand at a 16.5% annual growth rate to $84 billion, showcasing its robust growth prospects in the AI era.
See More
JPMorgan Updates Top Tech Stock Picks Amid Market Volatility
- New Tech Picks: JPMorgan added software companies JFrog and Palo Alto Networks to its top stock picks in April, indicating optimism for AI-related stocks, despite JFrog's 23% year-to-date decline, analysts believe it has significant AI growth potential.
- Market Rally: Following reports of a potential end to the Middle East conflict, all three major indexes posted gains on the last day of March, marking their best daily performance since May, even as oil prices fluctuated above $100 per barrel due to the war.
- Aramark's Return: JPMorgan reinstated food, uniform, and facilities provider Aramark to its top picks after the company provided a
See More
Eli Lilly Receives FDA Approval for New Drug Foundayo
- New Drug Approval: Eli Lilly announced that its once-daily GLP-1 drug Foundayo has received FDA approval and is set to launch on April 6 via the LillyDirect online platform, addressing strong market demand for weight loss medications and further solidifying its position in the obesity treatment market.
- Positive Market Outlook: Analysts forecast Foundayo to generate approximately $1.55 billion in sales this year, with projections growing to about $14.8 billion by 2030, indicating the drug's significant potential in the future market and its capacity to reshape obesity treatment paradigms.
- Significant Competitive Advantage: Compared to rival Novo Nordisk's Wegovy, Foundayo offers greater flexibility in dosing and dietary restrictions, and has demonstrated superior efficacy in clinical studies for diabetes patients, which may attract a broader patient base to choose this medication.
- Accelerated Strategic Transformation: Eli Lilly built up a substantial stockpile of the drug ahead of FDA approval to ensure a swift market response, showcasing the company's foresight and execution in its new drug launch strategy, thereby enhancing its competitiveness in the biopharmaceutical industry.
See More
Palo Alto Networks CEO Buys $10 Million in Stock Amid Market Decline
- Insider Buying Signal: CEO Nikesh Arora's $10 million stock purchase following a 33% decline in Palo Alto Networks' share price indicates strong confidence in the company's future value, potentially boosting market sentiment towards the stock.
- Market Reaction Analysis: Despite a general decline in cybersecurity stocks due to concerns over generative AI, Palo Alto Networks is well-positioned to benefit from increased demand for comprehensive cybersecurity solutions as enterprises face growing threats, suggesting a strategic advantage.
- Platform Strategy Success: The company reported 1,550 platform customers as of Q2, a 35% year-over-year increase, reflecting the effectiveness of its platformization strategy in enhancing customer retention and achieving a net revenue retention rate of 119%, indicating growing customer reliance on its services.
- Software Business Growth: While overall revenue growth is hampered by legacy hardware, Palo Alto's high-margin software solutions grew by 33% last quarter, demonstrating strong market competitiveness in addressing AI-driven cyber threats and positioning the company for accelerated future growth.
See More
Palo Alto Networks CEO Purchases Shares, Stock Rises
- CEO Share Purchase: The CEO of Palo Alto Networks recently purchased shares, leading to a rise in stock price on the afternoon of March 29, 2026, indicating management's confidence in the company's future, which may attract more investor interest.
- Market Performance Comparison: Despite the CEO's stock purchase, the analyst team noted that Palo Alto Networks was not included in the current list of top investment stocks, reflecting differing market perceptions of its future growth potential, which could influence investor decisions.
- Return Rate Analysis: According to The Motley Fool, their Stock Advisor service boasts an average return rate of 914%, significantly outperforming the S&P 500's 184%, indicating that investors should carefully consider potential returns when selecting stocks.
- Industry Competitive Dynamics: Amid rapid advancements in AI technology, market interest in Palo Alto Networks is rising, particularly due to its critical technology needs linked to industry giants like Nvidia and Intel, potentially opening new growth opportunities for the company.
See More
Palo Alto Networks CEO Buys Shares, Stock Rises
- Stock Price Surge: Shares of Palo Alto Networks rose following news of the CEO's stock purchase, indicating increased market confidence in the company's future and heightened investor trust in management.
- CEO Purchase: The CEO bought shares at afternoon prices on March 29, 2026, demonstrating a strong belief in the company's prospects, which may attract more investor attention to the firm.
- Market Reaction: This purchase triggered a positive market response, with the stock price increase reflecting investor confidence in corporate governance and management, potentially fostering further investment and shareholder support.
- Strategic Implications: The CEO's purchase not only acknowledges the company's value but may also signal upcoming aggressive growth strategies, further enhancing the company's competitive position in the market.
See More
Lockheed Martin Hacked, Exposing Sensitive Data
- Cybersecurity Threats: Lockheed Martin was recently targeted in a hacking breach that may have exposed sensitive data, including information on the F-35 fighter jet, highlighting the critical importance of protecting classified weapons data amid increasingly sophisticated cybersecurity threats.
- Growing Market Demand: As artificial intelligence advances, cybersecurity is expected to remain a crucial budget item for companies worldwide, driving demand for cybersecurity firms, particularly those that excel in innovation.
- CrowdStrike's Market Leadership: CrowdStrike Holdings' Falcon platform leverages AI to analyze device activity and detect suspicious patterns, with its total addressable market projected to grow from $149 billion to $325 billion by 2030, indicating strong growth potential.
- Zscaler's Unique Positioning: Zscaler specializes in cloud-native zero-trust security, generating $3 billion in annual sales, and the zero-trust security market is expected to expand at a 16.5% annual growth rate to $84 billion, showcasing its robust growth prospects in the AI era.
See More
JPMorgan Updates Top Tech Stock Picks Amid Market Volatility
- New Tech Picks: JPMorgan added software companies JFrog and Palo Alto Networks to its top stock picks in April, indicating optimism for AI-related stocks, despite JFrog's 23% year-to-date decline, analysts believe it has significant AI growth potential.
- Market Rally: Following reports of a potential end to the Middle East conflict, all three major indexes posted gains on the last day of March, marking their best daily performance since May, even as oil prices fluctuated above $100 per barrel due to the war.
- Aramark's Return: JPMorgan reinstated food, uniform, and facilities provider Aramark to its top picks after the company provided a
See More
Eli Lilly Receives FDA Approval for New Drug Foundayo
- New Drug Approval: Eli Lilly announced that its once-daily GLP-1 drug Foundayo has received FDA approval and is set to launch on April 6 via the LillyDirect online platform, addressing strong market demand for weight loss medications and further solidifying its position in the obesity treatment market.
- Positive Market Outlook: Analysts forecast Foundayo to generate approximately $1.55 billion in sales this year, with projections growing to about $14.8 billion by 2030, indicating the drug's significant potential in the future market and its capacity to reshape obesity treatment paradigms.
- Significant Competitive Advantage: Compared to rival Novo Nordisk's Wegovy, Foundayo offers greater flexibility in dosing and dietary restrictions, and has demonstrated superior efficacy in clinical studies for diabetes patients, which may attract a broader patient base to choose this medication.
- Accelerated Strategic Transformation: Eli Lilly built up a substantial stockpile of the drug ahead of FDA approval to ensure a swift market response, showcasing the company's foresight and execution in its new drug launch strategy, thereby enhancing its competitiveness in the biopharmaceutical industry.
See More
